Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Cataract surgery with toric intraocular lens implantation in patients with keratoconus

Search Title by author or title

Session Details

Session Title: Cataract Surgery Special Cases

Session Date/Time: Monday 12/09/2016 | 08:00-10:30

Paper Time: 08:24

Venue: Auditorium C6

First Author: : N.Visser THE NETHERLANDS

Co Author(s): :    V. Webers   N. Bauer   R. Nuijts              

Abstract Details

Purpose:

To evaluate clinical outcomes following toric intraocular lens (IOL) implantation in patients with cataract and keratoconus.

Setting:

University Eye Clinic Maastricht, the Netherlands.

Methods:

Sixteen patients (25 eyes) with stable mild to moderate keratoconus (Krumeich stage 1 and 2) underwent cataract surgery with toric IOL implantation (Acrysof SN6AT3-T9 or Rayner T-flex). Postoperatively uncorrected and best-corrected distance visual acuity (UDVA and BDVA), subjective refraction, Alpins vector analysis, surgically induced corneal astigmatism, posterior corneal astigmatism and IOL misalignment were evaluated.

Results:

Mean follow-up was 3 ±2 months . Preoperative BDVA was 0.36 ±0.16 LogMAR and corneal astigmatism 3.79 ±1.36 D (range 1.42–6.38 D). Postoperatively, UDVA and BDVA were 0.17 ±0.15 LogMAR and 0.10 ±0.10 LogMAR, respectively. Residual refractive astigmatism was -1.24 ±0.94 D and 52% of eyes achieved a refractive astigmatism of 1.0 D or less. Surgically induced corneal astigmatism was -0.22 ±0.62 D @ 136 degrees. The mean magnitude of posterior corneal astigmatism was -0.66 ±0.27 D. The mean correction index of 1.17 and magnitude of error of 0.34 D both indicate a general overcorrection. In 3 eyes, a realignment was performed.

Conclusions:

Cataract surgery with toric IOL implantation is an effective treatment option in patients with mild to moderate, stable keratoconus. However, care should be taken to prevent overcorrection.

Financial Disclosure:

... research is funded, fully or partially, by a competing company

Back to previous